Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2025-12-25 @ 4:51 AM
NCT ID: NCT03288818
Eligibility Criteria: Inclusion Criteria: * Documentation of diagnosis as evidenced by one or more clinical features consistent with mycosis fungoides cutaneous T-cell lymphoma * Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with requirements of the study * Skin biopsy specimen of representative lesion obtained at screening of study and deemed diagnostic of mycosis fungoides by principal investigator * Mycosis fungoides patients that have stage T2-4 N0-1 M0B0 disease * Availability of subject to be observed for up to 18 months post-screening evaluation * Life expectancy greater than 6 months Exclusion Criteria: * Pregnant or breast-feeding females * Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or the quality of the data * Patients diagnosed with Sezary syndrome; Sezary syndrome is equivalent to mycosis fungoides that develops to stage IVA/B with B2 (high blood tumor burden) involvement, and as such requires a more aggressive treatment regimen than Valchlor or TSEBT * Underlying medical condition including unstable cardiac disease, or other serious illness that would impair the ability of the patient to undergo treatment * Minimum 3 weeks since prior systematic treatment or phototherapy * Exclusion of people that do not understand the risks, such as decisionally-impaired individuals, prisoners, and vulnerable populations
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03288818
Study Brief:
Protocol Section: NCT03288818